Liu Yueyong, Huang Yurong, Wang Zeran, Huang Yong, Li Xiaohua, Louie Alexander, Wei Guangwei, Mao Jian-Hua
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.
Aging (Albany NY). 2013 Feb;5(2):111-9. doi: 10.18632/aging.100535.
FBXW7 acts as a tumor suppressor in numerous types of human cancers through ubiquitination of different oncoproteins including mTOR. However, how the mutation/loss of Fbxw7 results in tumor development remains largely unknown. Here we report that downregulation of mTOR by radiation is Fbxw7-dependent, and short-term mTOR inhibition by rapamycin after exposure to radiation significantly postpones tumor development in Fbxw7/p53 double heterozygous (Fbxw7+/-p53+/-) mice but not in p53 single heterozygous (p53+/-) mice. Tumor latency of rapamycin treated Fbxw7+/-p53+/- mice is remarkably similar to those of p53+/- mice while placebo treatedFbxw7+/-p53+/- mice develop tumor significantly earlier than placebo treated p53+/- mice. Furthermore, we surprisingly find that, although temporal treatment of rapamycin is given at a young age, the inhibition of mTOR activity sustainably remains in tumors. These results indicate that inhibition of mTOR signaling pathway suppresses the contribution of Fbxw7 loss toward tumor development.
FBXW7通过泛素化包括mTOR在内的不同癌蛋白,在多种类型的人类癌症中发挥肿瘤抑制作用。然而,Fbxw7的突变/缺失如何导致肿瘤发生在很大程度上仍不清楚。在此我们报告,辐射导致的mTOR下调是Fbxw7依赖性的,并且在辐射后用雷帕霉素进行短期mTOR抑制可显著推迟Fbxw7/p53双杂合(Fbxw7+/-p53+/-)小鼠的肿瘤发生,但对p53单杂合(p53+/-)小鼠无效。雷帕霉素处理的Fbxw7+/-p53+/-小鼠的肿瘤潜伏期与p53+/-小鼠非常相似,而安慰剂处理的Fbxw7+/-p53+/-小鼠比安慰剂处理的p53+/-小鼠更早发生肿瘤。此外,我们令人惊讶地发现,尽管雷帕霉素是在年轻时进行短期处理,但mTOR活性的抑制在肿瘤中可持续存在。这些结果表明,抑制mTOR信号通路可抑制Fbxw7缺失对肿瘤发生的影响。